The Y in Psychiatry
"The Y in Psychiatry" – a pragmatically endearing podcast talking to the med students, residents, fellows, and attendings of the medicine world about the nuances of psychiatry.
Each episode are discussions exploring the intersections of the mental health, medicine, and the human experience.
Together, we'll uncover the hidden "Y" – the compelling reasons, profound insights, and groundbreaking discoveries shaping the psychiatric landscape.
So grab a seat, warm beverage, tune in, and let's embark on this journey to unlock the mysteries of the human psyche, only on "The Y in Psychiatry."
Find articles on our episodes here:
Episodes
21 episodes
Cobenfy Unleashed: Psychiatry's New Frontier
Cobenfy doesn't block dopamine — and that's the whole point. In this special episode, we step away from the bipolar just a bit to unpack the first genuinely new mechanism in schizophrenia treatment in decades. We break down how Cobenfy pairs xa...
The Bipolar Brain on Overdrive: Dopamine, Serotonin & Circuits
We're now tracing how dopamine and serotonin imbalances map onto psychomotor agitation, depression, and that “too much energy” feel of mania. We also stop by the basal ganglia–thalamus–sensorimotor loop, the ventrolateral and ventromedial prefr...
Ticket to Ride: The Bipolar Comorbidity Express Explored
All aboard the Bipolar Express to unpack one of the messiest puzzles in psych: why diagnosing Bipolar Disorder sometimes feels like trying to solve a Rubik’s cube — when there could also be ADHD, anxiety, personality disorders, substance use, s...
The B in Bipolar Stands for ‘Be Careful’: Diagnosing Bipolar Spectrum Disorders
We make a tokyo drift to a new topic: bipolarism! Lets jump in and manically (responsibly) get through as much as we can with depression and its interfaces. Hope you brought your shovel cause we're about to DIGFAST.
Late Life Depression: When the Golden Years Turn Grey (and the SSRIs Don't Shine)
It never gets old to talk about late-life depression. Lets explore why growing older can sometimes mean growing sadder.We prance through executive dysfunction, vascular woes, inflammatory fires, and amyloid beta blues. We’ll ...
Liver and (Don't) Let Die: Navigating Psychotropic Use in Cirrhosis
Lets do the discussion tango between the liver and psychotrops: today we're focusing on patients with cirrhosis. Discussing 1st-pass metabolism, phase 1 and 2 metabolisms, plasma protein binding, fluid overload, and the implications of these pr...
Kidneys don't Kid Around with Antidepressants
Lets explore the kidneys in psychiatry and discuss the impact of renal disease on medication management. No kidding these kidneys can be curiously be essential to know about for psychiatry.
Forgetfully Down: Neurocognitively Impaired Populations and Depression
Explore the intersection of depression and neurocognitive disorders in elderly patients. The discussion highlights the challenges in differentiating between depression and apathy, the importance of accurate diagnosis, and the appropriate pharma...
More Potentially Impotent Side Effects from the Antidepressants - Part 2
A continuation of Part one of potentially potent side effects of SSRIs - we now dive into the dark yet enlightening side effects of conventional antidepressants. From weight gain to sexual side effects and hyponatremia.Please dose this e...
Potentially Potent Side Effects of the SSRIs - Part 1
We explore the potentially potent side effects of SSRIs. This includes the risks of switching to mania, the role of mood stabilizers, the increased risk of suicidality in younger patients, and the common side effects of nausea and vomiting....
Depression - When All Else Doesn't Work
When the algorithm for treating depression runs out of runway, we'll come to your aid with this podcast.Tune in as we briefly review the treatments reserved for the refractive cases of depression.
Depression - Continuing the Serotonin Soiree: Fluoxetine and Fluvoxamine
I hope you're in business casual, whatever that means, and join us this evening for a soiree that will give Bridgerton a run for its money. Okay not really but we only hope -especially when we'll be jiving to the conversation of fluoxetine and ...
Depression - Second Steps - Psychopharmacology Options with SSRIs
Review with us the first line agents when considering psychopharmacology for your patients. The granular details can be daunting sometimes, but at the very least they'll help you be aware of some cautionary contexts, build your psychopharm data...
Depression - First Steps - Talk about it.
Nonpharmacologic treatment options for depression and our options of holistic approaches, therapies, and lifestyle changes that offer powerful tools for managing and overcoming this challenge.Learn how small changes in your patients rou...
Depression Decisions: To SSRI or SNRI
Lets talk about the do’s and don’ts of depression.They discuss everything from why we need to treat it, how to diagnose it, and its different treatment modalities. Depression decisions need to be made and this podcast can help you make t...
Very Vivacious Vortioxetine
Trek through the landscape of vortioxetine via neurotransmitters, GABA interneurons, and serotonin receptors, all with the goal of making this complex antidepressant understandable.The hosts' accents might challenge your ears, but their ...
The Enigmatic Enigma: Decoding the Mechanisms of Antidepressants
We jump into antidepressants.We unravel the enigma surrounding antidepressants, delving into how they work in the brain and why they can take time to have an effect. Discover the hidden mechanisms and uncover the secrets behind th...
Trailer 2: What are we four?
We heard your feedback and decided to introduce another trailer with a little bit more background on the hosts behind the podcast. Be sure to check it out and give us some kudos, or hopefully some constructive feedback.
Bridging the Mood Gap: A Neuro-Tour of the Major Brain Networks
Join our whirlwind tour in the moody labyrinth of depression on "The Y in Psychiatry". This is not your a usual clinical field trip - it's a rollercoaster ride through brain inheritance battles, medical conundrums, and psychosocial puppetry. We...
